Home Analyst Ratings H.C. Wainwright lowers SCYNEXIS Inc. rating to buy and sets price...

H.C. Wainwright lowers SCYNEXIS Inc. [SCYX] rating to buy and sets price target at $20

H.C. Wainwright took its SCYNEXIS Inc. [SCYX] rating to the equivalent of a Buy, and the price target to ‎‎$20 from $35, in a research note dated Dec 28, 2020. That figure represents around a 64.35% premium ‎from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with ‎Needham’s analysts upgrading the shares from “a Hold” rating to “a Buy” rating in a research note to ‎investors issued in mid July. Meanwhile, Maxim Group had launched its coverage on SCYX with “Buy”, ‎in a research note produced for clients June 27, 2018. In addition, there was a new coverage from ‎Guggenheim on October 24, 2017. The research firm rated SCYX “a Buy”.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Is SCYNEXIS Inc. [NASDAQ:SCYX] a Good Buy Right Now?

It should be noted that SCYX ‎technical indicators for short, intermediate as well as long term progress have placed an overall ‎average of 48% as Buy. The average signal changed from 16% Sell in the last week and compares with ‎‎24% Sell in the past month. Data from SCYNEXIS Inc.’s Trend Spotter indicated that the signals were ‎Bullish. The stock current average is 0.34 million shares in the past 20 days and the short term average ‎signal indicates a 100% Buy. In the last 50 days, the average trading volume was 0.2 million shares while ‎the medium term average advocated for Hold. The average long-term signal stands at 50% Buy and the ‎‎100-day average volume stands at 0.13 million shares.‎‎

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

SCYX Price Performance

On Wall Street, SCYNEXIS Inc. [NASDAQ:SCYX] finished Thursday’s ‎session up 1.28% at $7.14. The stock went up to $7.18 at the same session while its lowest single day ‎price was $6.92. In the last five days, it saw a rise of about 20.40%, SCYNEXIS Inc. shares dropped by ‎almost -21.54% since the beginning of the year. However, the share price has dropped to as low as -‎‎40.99% below its one year high. On 01/08/20, the company shares recorded $12.10, the highest single-‎day price it has got to in the last 52-weeks and a 52-week low was seen on 10/01/20, the same year at ‎‎$4.20. The company’s shares have declined by -16.66% in the past year. The 50-day SMA achieved is ‎‎$5.90 while the 200-day SMA is $6.80. Volume dropped to 0.25 million from 0.73 million in the previous ‎session.‎‎

SCYX Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is ‎perceived around 6.98 level, and in case of violation of this particular level, it will cause more drop to ‎‎6.82 level. On the upper level, 7.34 is still the key resistance. The stock may increase to the subsequent ‎resistance at 7.24. The Relative Strength Index (RSI) pinned on the 14-day chart is 57.04, implying a ‎neutral technical stance while the MACD stands at -0.12, meaning price will decrease in the next ‎trading period. Percent R indicator moved to 42.11%, implying low price movement. Stochastic %K at ‎‎48.68% suggest selling the stock.‎‎

What is the short interest in SCYNEXIS Inc.?

Short interest in the SCYNEXIS Inc. stock has ‎plunged, decreasing by -0.15 million shares to total 0.36 million shares on Dec 14, 2020. The interest ‎had seen shares on Nov 12, 2020 stand at 0.2 million, data from Yahoo Finance shows. The increase of ‎‎43.09% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ‎ratio) moved to while the shorted shares account for just 3.98% of the overall float for the stock.‎‎

SCYNEXIS Inc.’s Biggest Shareholders: Who Owns SCYNEXIS Inc. [SCYX]?

Filings by Federated ‎Global Investment Manag showed that the firm now holds a total of 1,909,930 shares or roughly ‎‎17.46% of the outstanding SCYX shares. This means their shares have reduced by 0 from the 1,909,930 ‎the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, Stonepine Capital ‎Management LLC updated stake is worth $10,220,737. During the last quarter, Avidity Partners ‎Management LP 1,086,706 of its shares in SCYNEXIS Inc. while Caxton Corp. bought 39,759 shares. The ‎Puissance Capital Management LP’s holdings currently number 311,143 shares at $2221561.02. ‎According to the firm’s last 13F report, The Vanguard Group, Inc. shares in the company at filing stood ‎at 277,723 shares, roughly $1,846,858.‎‎

SCYX Earnings Forecast For The Current Quarter

SCYNEXIS Inc. [SCYX] is expected to report ‎strong earnings results for the quarter ending on Dec 2020. Consensus estimates give the company ‎expected an earnings per share of -$0.96 for Dec 2020. Looking further ahead, the company is ‎expected to report an EPS of -$0.72 for Mar 2021. ‎‎

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

SCYX Earnings Estimates For The Current ‎Year

In terms of EPS for the 2020, estimate put it at -2.24, higher than that of FY19 by $7.36. ‎Estimates put this year’s earnings growth at 76.70%, -40.60% for the next. ‎

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Why AbCellera Biologics Inc. (ABCL) stock faced negativity on Tuesday?

AbCellera Biologics Inc. (ABCL) shares lost 2.13% in after-hours on Tuesday, June 22, 2021, and closed the day at $21.60 per share. Earlier, ABCL's...

Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?

Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with...

Comstock Mining Inc. (LODE) stock soar during pre-market trading. What’s happening?

Comstock Mining Inc. (NASDAQ: LODE) stock gained by 1.14% at last close while the LODE stock price surged by 3.10% in the pre-market trading...

Why MediciNova Inc (MNOV) stock facing negativity since Monday’s after-hours?

MediciNova Inc. (MNOV) shares lost 5.71% in after-hours on Monday, June 21, 2021, and the plummeting continues in the pre-market session on Tuesday as...

Histogen Inc. (HSTO) stock plunged during pre-market trading. What’s driving it low?

Histogen Inc. (NASDAQ: HSTO) stock gained by 16.16% at last close whereas the HSTO stock price declines by 2.73% in the pre-market trading. Histogen...

Pyxis Tankers Inc. (PXS) stock fell during pre-market trading. Why so?

Pyxis Tankers Inc. (NASDAQ: PXS) stock declined by 0.06% at the last close while the PXS stock price plunged by 6.15% in the pre-market...

Why STAAR Surgical Company (STAA) stock went up on Tuesday?

STAAR Surgical Company (STAA) shares rose 5.84% in after-hours on Tuesday, June 22, 2021, and closed the day at $151.25 per share. earlier in...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.